IMedis is an artificial intelligence platform analyzing medical information to identify previously undetected patients that are candidates for early and preventative care. Our vision is to increase early detection rates, help deliver better clinical outcomes, lower medical costs and mitigate clinical risks. We are seeking collaboration opportunities with medical institutions in the US for the purpose of joint research and development of our future products.
Founded in early 2018, IMedis was created with the aim of improving early detection of cancer and other life-threatening conditions via our novel approach of comparing “vision” and “text” for discrepancies. With radiology teams challenged by ever-increasing workloads, we uniquely solve for doing more with less – improving performance while reducing risk.
B2C, B2B
1 to 25
Seed
$1,300,000
Scaling Up
2018
Medical Devices
Life Sciences Tools & Services
Healthcare
Biotechnology
Clinical Indications
Fully Utilize Every CT Scan for Early Detection
Healthcare Technology
Increase Efficiency
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
Software & Hardware
N/A
AI/ML Professionals
Want to work at iMedis Medical?
We can introduce you to the right person at iMedis Medical
Potential Customers
Interested in what they do or partnership?
Learn more about how they work